z-logo
open-access-imgOpen Access
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Author(s) -
Burlando Martina,
Muracchioli Andrea,
Cozzani Emanuele,
Parodi Aurora
Publication year - 2021
Publication title -
case reports in dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.338
H-Index - 18
ISSN - 1662-6567
DOI - 10.1159/000514198
Subject(s) - case and review
Psoriasis and vitiligo are 2 multifactorial immune-mediated diseases, partially sharing pathogenetic underpinnings. Their coexistence in the same patient, although uncommon, is documented in the literature. Further, several cases of vitiligo induced by biological drugs in psoriatic patients are reported. However, improvements in psoriasis and pre-existing vitiligo after the introduction of biological therapy are also described. To date, anti-TNF-alpha is the most cited group of biological drugs that induce new-onset vitiligo or progression of pre-existence vitiligo in psoriatic patients. Even anti-IL-12/23 class would seem to induce vitiligo (as in our case) or even worse it. Anti-IL-17 drugs induce a progression of pre-existing vitiligo while, to date, no cases are reported in literature considering anti-IL-23 class.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here